The Vaccines

	Effectiveness
	General	UK variant	South Africa variant	Brazil variant
	78 %	70-80%	10%	yes
	95 %	90-95%	62%	yes
	94.5 %	90-95%	62%	yes
	73%	70	47-55%	less efficient
	91.6 %	?	60	?
	50.4 %	?	?	?
	96.4 %	86.3%	55.4 %	?
	81 %	?	?	?

Some of the most important parameters on efficacy of the vaccines.

In the following table you can find some of the most practical data. Prices are actually dependent on agreement between nations and producers. For example the Pfizer BioNTech vaccine had substantial financial help from German and EU institutions, thus the price in EU is lower than in USA. Viceversa Moderna has a lower price in USA than in the EU

		N. doses	Days Gap	Price per dose	EU approval	USA approval	Partners	Technique
UK		2	85	UK: 3$ US: 4$ EU: 2.15$	Yes	ongoing		viral vector
DE USA		2	21	EU: 14.70$ US: 19.50$	Yes	Yes	Sanofi	mRNA
USA		2	28	EU: 18$ US: 15$	Yes	Yes		mRNA
USA		1		8.50$	Yes	Yes		viral vector
RU		2	21-56	10 $	ongoing	not applied		viral vector
ZH		2	21	60$	not applied	not applied		viral vector
USA		2	21	16$	ongoing			protein sub-units
IN		2	28	2.90$	not applied	not applied		viral vector
DE		2	28	12.25$	ongoing		GSK, Bayer & Novartis	mRNA

Advertisement